Search Browse Earnings

Hepion Pharmaceuticals, Inc. — SlamSEC

Hepion Pharmaceuticals, Inc.

OTC:HEPAOTC:CTRVP

Pharmaceutical Preparations·EDISON, NJ

Overview All Filings Sum Fin Credit Insiders Governance

Overview All Filings Sum Fin Credit Insiders Governance

Summary Financials

Revenue

$0

FY 2023

Adj. EBITDA

-$19.3M

FY 2025

Net Income

-$13.2M

FY 2025

EPS (Diluted)

-$107.35

FY 2025

Stock Price

—

52W Range

—

P/E Ratio

—

Market Cap

—

Cash

$6.0M

FY 2019

Total Debt

$2.9M

FY 2025

Net Cash

$3.1M

FY 2025

Enterprise Value

—

Debt / EBITDA

0.2x

FY 2023

EV / EBITDA

—

Employees

—

CEO

Foster Robert T